Neurotherapeutics
DisciplineNeurology
LanguageEnglish
Edited byMaral Mouradian
Publication details
History2004-present
Publisher
Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics
FrequencyQuarterly
7.620 (2020)
Standard abbreviations
ISO 4Neurotherapeutics
Indexing
ISSN1933-7213 (print)
1878-7479 (web)
LCCN2006215616
OCLC no.82448136
Links

Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).

Abstracting and indexing

The journal is abstracted and indexed in:

According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.620.[1]

References

  1. "Neurotherapeutics". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate. 2020.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.